Alliance Pharma plc (APH) to Issue Dividend of GBX 0.44 on January 11th
Alliance Pharma plc (LON:APH) declared a dividend on Wednesday, September 13th, Upcoming.Co.Uk reports. Shareholders of record on Thursday, December 21st will be paid a dividend of GBX 0.44 ($0.01) per share on Thursday, January 11th. This represents a dividend yield of 0.84%. The ex-dividend date is Thursday, December 21st. The official announcement can be accessed at this link.
Shares of Alliance Pharma (APH) traded up GBX 1 ($0.01) on Friday, hitting GBX 62.50 ($0.84). 320,179 shares of the company’s stock were exchanged, compared to its average volume of 364,843. Alliance Pharma has a 52 week low of GBX 41.78 ($0.56) and a 52 week high of GBX 63 ($0.85).
APH has been the topic of a number of research reports. FinnCap reissued a “buy” rating and issued a GBX 58 ($0.78) target price on shares of Alliance Pharma in a research note on Thursday, August 24th. Numis Securities reissued a “buy” rating and issued a GBX 66 ($0.89) target price (down previously from GBX 71 ($0.96)) on shares of Alliance Pharma in a research note on Friday, December 1st. Investec initiated coverage on shares of Alliance Pharma in a research note on Wednesday, September 13th. They issued a “buy” rating and a GBX 59 ($0.79) target price on the stock. Finally, N+1 Singer reissued a “not rated” rating on shares of Alliance Pharma in a research note on Wednesday, September 13th.
TRADEMARK VIOLATION NOTICE: “Alliance Pharma plc (APH) to Issue Dividend of GBX 0.44 on January 11th” was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece can be viewed at https://www.dailypolitical.com/2017/12/16/alliance-pharma-plc-aph-to-issue-dividend-of-gbx-0-44-on-january-11th.html.
About Alliance Pharma
Alliance Pharma plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in acquisition, marketing and distribution of pharmaceutical products. The Company operates in various business areas, such as Hydromol, secondary care, community and consumer products, established products and international.
Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.